The Effect of Floorball on Health and Performance in Subjects With Lifestyle Diseases

Type2 Diabetes, Cardiovascular Diseases Clinical Trial

Official title:

The Effect of Floorball on Health Parameters and Performance in Subjects With Lifestyle Diseases

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03372005
• Other study ID #: Floorball
• Status: Active, not recruiting
• Phase: N/A
• Start date: September 12, 2017
• Est. completion date: June 27, 2020

Study information

• Verified date: May 2019
• Source: University of Copenhagen
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To investigate the effect of floorball on health and performance in subjects with either type 2 diabetes or cardiovascular diseases.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 500
• Est. completion date: June 27, 2020
• Est. primary completion date: May 27, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Diagnosed with type 2 diabetes

• Diagnosed with a cardiovascular disease (bp >140/90mmHg)

• Physical activity <2 hours pr. week.

• Not participating in any regular physical activity the last 2 years

Exclusion Criteria:

• age <18 years

• Injuries that prevent the subject from playing floorball

• Type 1 diabetics

• Alcohol >14 units pr. week.

• Pregnancy

• Participation in other scientific studies

• Abuse of illegal drugs

• other known serious diseases

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Type2 Diabetes, Cardiovascular Diseases

Intervention

Behavioral:
• Floorball
This intervention will have one week of testing before the first 12 weeks of floorball, followed by one week of testing before the last 27 week training period.

Locations

Country	Name	City	State
Denmark	August Krogh Building	Copenhagen

Sponsors (1)

Lead Sponsor	Collaborator
University of Copenhagen

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HbA1c	Long term blood sugar concentration	Changes from baseline measured after 12 weeks and 39 weeks
Primary	Blood pressure		Changes from baseline measured after 12 weeks and 39 weeks